Access to respiratory syncytial virus preventive tools for neonates and infants in Europe

Lancet Infect Dis. 2024 Apr;24(4):343-345. doi: 10.1016/S1473-3099(24)00084-7. Epub 2024 Feb 19.

Authors

Caitlin Pley¹, Beate Kampmann²

Affiliations

¹ Charité Center for Global Health, Charité Universitätsmedizin Berlin, Berlin 10117, Germany.
² Charité Center for Global Health, Charité Universitätsmedizin Berlin, Berlin 10117, Germany; Vaccine Centre, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: beate.kampmann@charite.de.

PMID: 38387473
DOI: 10.1016/S1473-3099(24)00084-7

No abstract available

MeSH terms

Europe
Humans
Infant
Infant, Newborn
Respiratory Syncytial Virus Infections* / prevention & control
Respiratory Syncytial Virus, Human*

Grants and funding